95 related articles for article (PubMed ID: 7561939)
1. Duchenne-like myopathy in double-mutant mdx mice expressing exaggerated mast cell activity.
Granchelli JA; Pollina C; Hudecki MS
J Neurol Sci; 1995 Jul; 131(1):1-7. PubMed ID: 7561939
[TBL] [Abstract][Full Text] [Related]
2. Enhanced sensitivity of mdx mice to intramuscular injection of compound 48/80.
Granchelli JA; Hudecki MS; Pollina CM
Res Commun Chem Pathol Pharmacol; 1994 Jun; 84(3):351-62. PubMed ID: 7938907
[TBL] [Abstract][Full Text] [Related]
3. Myotonic ADR-MDX mutant mice show less severe muscular dystrophy than MDX mice.
Krämer R; Lochmüller H; Abicht A; Rüdel R; Brinkmeier H
Neuromuscul Disord; 1998 Dec; 8(8):542-50. PubMed ID: 10093060
[TBL] [Abstract][Full Text] [Related]
4. Regeneration and myogenic cell proliferation correlate with taurine levels in dystrophin- and MyoD-deficient muscles.
McIntosh LM; Garrett KL; Megeney L; Rudnicki MA; Anderson JE
Anat Rec; 1998 Oct; 252(2):311-24. PubMed ID: 9776086
[TBL] [Abstract][Full Text] [Related]
5. A role for mast cells in the progression of Duchenne muscular dystrophy? Correlations in dystrophin-deficient humans, dogs, and mice.
Gorospe JR; Tharp MD; Hinckley J; Kornegay JN; Hoffman EP
J Neurol Sci; 1994 Mar; 122(1):44-56. PubMed ID: 8195802
[TBL] [Abstract][Full Text] [Related]
6. Breeding of the gad-mdx mouse: influence of genetically induced denervation on dystrophic muscle fibers.
Suh JG; Yamazaki A; Tomita T
Lab Anim Sci; 1994 Feb; 44(1):42-6. PubMed ID: 8007658
[TBL] [Abstract][Full Text] [Related]
7. How does dystrophin deficiency lead to muscle degeneration?--evidence from the mdx mouse.
McArdle A; Edwards RH; Jackson MJ
Neuromuscul Disord; 1995 Nov; 5(6):445-56. PubMed ID: 8580726
[TBL] [Abstract][Full Text] [Related]
8. Somatic reversion/suppression of the mouse mdx phenotype in vivo.
Hoffman EP; Morgan JE; Watkins SC; Partridge TA
J Neurol Sci; 1990 Oct; 99(1):9-25. PubMed ID: 2250176
[TBL] [Abstract][Full Text] [Related]
9. Eosinophilia of dystrophin-deficient muscle is promoted by perforin-mediated cytotoxicity by T cell effectors.
Cai B; Spencer MJ; Nakamura G; Tseng-Ong L; Tidball JG
Am J Pathol; 2000 May; 156(5):1789-96. PubMed ID: 10793090
[TBL] [Abstract][Full Text] [Related]
10. Consequence of parvalbumin deficiency in the mdx mouse: histological, biochemical and mechanical phenotype of a new double mutant.
Raymackers JM; Debaix H; Colson-Van Schoor M; De Backer F; Tajeddine N; Schwaller B; Gailly P; Gillis JM
Neuromuscul Disord; 2003 Jun; 13(5):376-87. PubMed ID: 12798793
[TBL] [Abstract][Full Text] [Related]
11. The frequency of revertants in mdx mouse genetic models for Duchenne muscular dystrophy.
Danko I; Chapman V; Wolff JA
Pediatr Res; 1992 Jul; 32(1):128-31. PubMed ID: 1635838
[TBL] [Abstract][Full Text] [Related]
12. Muscular dystrophy in mice caused by two different alterations of dystrophin gene.
Rowiński J; Kozłowska H; Sulikowska-Rowińska A; Rejment E
Folia Histochem Cytobiol; 2001; 39(2):119-20. PubMed ID: 11374785
[TBL] [Abstract][Full Text] [Related]
13. Muscle-bone interactions in dystrophin-deficient and myostatin-deficient mice.
Montgomery E; Pennington C; Isales CM; Hamrick MW
Anat Rec A Discov Mol Cell Evol Biol; 2005 Sep; 286(1):814-22. PubMed ID: 16078270
[TBL] [Abstract][Full Text] [Related]
14. Smooth muscle-specific dystrophin expression improves aberrant vasoregulation in mdx mice.
Ito K; Kimura S; Ozasa S; Matsukura M; Ikezawa M; Yoshioka K; Ueno H; Suzuki M; Araki K; Yamamura K; Miwa T; Dickson G; Thomas GD; Miike T
Hum Mol Genet; 2006 Jul; 15(14):2266-75. PubMed ID: 16777842
[TBL] [Abstract][Full Text] [Related]
15. Comparison of skeletal muscle pathology and motor function of dystrophin and utrophin deficient mouse strains.
van Putten M; Kumar D; Hulsker M; Hoogaars WM; Plomp JJ; van Opstal A; van Iterson M; Admiraal P; van Ommen GJ; 't Hoen PA; Aartsma-Rus A
Neuromuscul Disord; 2012 May; 22(5):406-17. PubMed ID: 22284942
[TBL] [Abstract][Full Text] [Related]
16. Myonuclear apoptosis in dystrophic mdx muscle occurs by perforin-mediated cytotoxicity.
Spencer MJ; Walsh CM; Dorshkind KA; Rodriguez EM; Tidball JG
J Clin Invest; 1997 Jun; 99(11):2745-51. PubMed ID: 9169505
[TBL] [Abstract][Full Text] [Related]
17. Improvement in survival and muscle function in an mdx/utrn(-/-) double mutant mouse using a human retinal dystrophin transgene.
Gaedigk R; Law DJ; Fitzgerald-Gustafson KM; McNulty SG; Nsumu NN; Modrcin AC; Rinaldi RJ; Pinson D; Fowler SC; Bilgen M; Burns J; Hauschka SD; White RA
Neuromuscul Disord; 2006 Mar; 16(3):192-203. PubMed ID: 16487708
[TBL] [Abstract][Full Text] [Related]
18. Severe cardiomyopathy in mice lacking dystrophin and MyoD.
Megeney LA; Kablar B; Perry RL; Ying C; May L; Rudnicki MA
Proc Natl Acad Sci U S A; 1999 Jan; 96(1):220-5. PubMed ID: 9874799
[TBL] [Abstract][Full Text] [Related]
19. Factors inducing mast cell accumulation in skeletal muscle.
Lefaucheur JP; Gjata B; Sebille A
Neuropathol Appl Neurobiol; 1996 Jun; 22(3):248-55. PubMed ID: 8804027
[TBL] [Abstract][Full Text] [Related]
20. Effects of contractile activity on muscle damage in the dystrophin-deficient mdx mouse.
McArdle A; Edwards RH; Jackson MJ
Clin Sci (Lond); 1991 Apr; 80(4):367-71. PubMed ID: 1851074
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
